Regenevida
Recombinetics is a global biotechnology leader specializing in animal gene editing for biomedical research, animal agriculture, and human therapeutics. Their mission is to advance biomedical innovation through services, products, and expertise built on relationships and integrity, focusing on developing genetically engineered animals, including models for human diseases and improved livestock. They are committed to transparency, collaboration, and continuous improvement in their processes and products.
Industries
Nr. of Employees
small (1-50)
Regenevida
Patents
Products
Custom genetically engineered animals and germplasm
Delivered genetically modified animals and associated germplasm lines for research and commercialization across biomedical and agricultural applications.
Custom genetically engineered animals and germplasm
Delivered genetically modified animals and associated germplasm lines for research and commercialization across biomedical and agricultural applications.
Services
End‑to‑end creation of swine models carrying precise human disease or reporter mutations for preclinical evaluation.
Precision introduction and deployment of production and health traits into commercial livestock lines using gene‑editing and laboratory breeding techniques.
Development services to generate host animals and protocols intended to support growth of human cells, tissues, or organs for regenerative medicine research.
Services for in vitro embryo production, cloning, and reproductive interventions to produce founder or recipient animals for propagation of edited genotypes.
Sequence analysis workflows using short‑ and long‑read technologies to validate edits, detect unintended integrations, and provide quality control reporting for genetic products.
End‑to‑end creation of swine models carrying precise human disease or reporter mutations for preclinical evaluation.
Precision introduction and deployment of production and health traits into commercial livestock lines using gene‑editing and laboratory breeding techniques.
Development services to generate host animals and protocols intended to support growth of human cells, tissues, or organs for regenerative medicine research.
Services for in vitro embryo production, cloning, and reproductive interventions to produce founder or recipient animals for propagation of edited genotypes.
Sequence analysis workflows using short‑ and long‑read technologies to validate edits, detect unintended integrations, and provide quality control reporting for genetic products.
Expertise Areas
- Animal gene editing
- Large‑animal disease model development
- Xenotransplantation and regenerative medicine
- Precision breeding and livestock genetics
Key Technologies
- CRISPR/Cas genome editing
- TALEN gene editing
- Homology‑directed repair (HDR)
- In vitro embryo production and cloning
News & Updates
Recombinetics merged efforts with Makana Therapeutics, focusing on solving organ shortage issues through xenotransplantation.
A collaborative project to develop pig models of Osteogenesis Imperfecta to better understand and treat the disease.
Funding from NIH to develop a pig model of the aggressive brain tumor, glioblastoma.
A collaborative project to develop gene editing solutions for bovine tuberculosis in Ireland and Northern Ireland.
Development of piglets that are naturally castrated, eliminating the need for surgical castration.
Discussion on the future of gene-edited animals in agriculture and food supply.
Recombinetics merged efforts with Makana Therapeutics, focusing on solving organ shortage issues through xenotransplantation.
A collaborative project to develop pig models of Osteogenesis Imperfecta to better understand and treat the disease.
Funding from NIH to develop a pig model of the aggressive brain tumor, glioblastoma.
A collaborative project to develop gene editing solutions for bovine tuberculosis in Ireland and Northern Ireland.
Development of piglets that are naturally castrated, eliminating the need for surgical castration.
Discussion on the future of gene-edited animals in agriculture and food supply.